Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced today their combination to establish a new pan-European leader in their field. Backed by their common shareholder, Keensight Capital, one …
Biovian, a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the appointment of Monica Lazaro as US East Coast Business Development Director, effective January 2nd, 2024. Monica will play a …
We are thrilled to announce that Biovian will be exhibiting at the upcoming Oncolytic Virotherapy Summit, scheduled to take place from December 12-14 in the vibrant city of Boston, MA. As part of this summit, …
We invite you to explore the recent article “Next Level Biopharmaceuticals” featured in the Business Focus Magazine’s latest issue. Business Focus Magazine interviewed Biovian’s CEO and co-founder Antti Nieminen about Biovian’s growth story and position …
Biovian Oy, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, announces a major investment of over €50 million to expand its manufacturing facility in Turku, Finland. The new facility will cover an …
We are thrilled to announce that Biovian will be participating in the 15th Annual Bioprocessing Summit in Boston, scheduled to take place from August 14-17, 2023. This premier event brings together industry leaders and experts …
We are delighted to welcome Dr. Uwe Gottschalk to Biovian’s Board of Directors. “At Keensight, we are very pleased to welcome Uwe to the Board of Biovian” said Dr. Pierre Remy, Chairman of the Board. …
What does a project manager do and what is needed to be successful in such a position? The job title has a broad meaning and job descriptions for project managers vary greatly. Even within the …
Biovian Oy announces that its Board of Directors has named Antti Nieminen, as a Chief Executive Officer, effective January 1st, 2022. Nieminen succeeds Co-Founder Dr. Knut Ringbom, who will transition to Senior Advisor of Biovian, …
Outsourcing as a business model within the Life Science-industry is growing year by year. Choosing the right contract development and manufacturing organization (CDMO) has become an important factor for the success of drug product development. …
